Predict your next investment

Corporation
INDUSTRIAL | Basic Materials / Chemicals
greenbiologics.com

See what CB Insights has to offer

Total Raised

$112.7M

Investors Count

9

Deal Terms

2

Green Biologics Funding, Green Biologics Valuation & Green Biologics Revenue

9 Fundings

Green Biologics's latest funding round was a Debt for $34M on January 21, 2015.

Green Biologics's valuation in December 2013 was $71.35M.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

1/21/2015

Debt

$34M

1

1/21/2015

Series C

$99M

10

12/2/2013

Series B

$99M

$71.35M

10

3/7/2013

Grant - II

10

11/16/2010

Grant

10

Date

1/21/2015

1/21/2015

12/2/2013

3/7/2013

11/16/2010

Round

Debt

Series C

Series B

Grant - II

Grant

Amount

$34M

$99M

$99M

Investors

Valuation

$71.35M

Revenue

Sources

1

10

10

10

10

Green Biologics Deal Terms

2 Deal Terms

Green Biologics's deal structure is available for 2 funding rounds, including their Series B from December 02, 2013.

Round

Series B

Series A

Funding Date

$99M

$99M

Pre-Money Valuation

Post-Money Valuation

Amount Raised

$99M

$99M

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

$99M

$99M

Board Voting

$99M

$99M

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Series B

$99M

$99M

$99M

$99M

Series A

$99M

$99M

$99M

$99M

Green Biologics Investors

9 Investors

Green Biologics has 9 investors. Swire Pacific invested in Green Biologics's Series C funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

12/2/2013

1/21/2015

2
Series B, Series C (2015)

Holding Company

Hong Kong

00/00/0000

00/00/0000

Sofinnova Partners

Subscribe to see more

Venture Capital

France

00/00/0000

00/00/0000

Tennenbaum Capital Partners

Subscribe to see more

Debt & Specialty Finance

California

00/00/0000

00/00/0000

Oxford Capital Partners

Subscribe to see more

Venture Capital

United Kingdom

00/00/0000

00/00/0000

Morningside Technology Ventures

Subscribe to see more

Venture Capital

Hong Kong

First funding

12/2/2013

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Last Funding

1/21/2015

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Investor

Sofinnova Partners

Tennenbaum Capital Partners

Oxford Capital Partners

Morningside Technology Ventures

Rounds

2
Series B, Series C (2015)

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Board Seats

Type

Holding Company

Venture Capital

Debt & Specialty Finance

Venture Capital

Venture Capital

Location

Hong Kong

France

California

United Kingdom

Hong Kong

Green Biologics Acquisitions

1 Acquisition

Green Biologics acquired 1 company. Their latest acquisition was GreenFlame on January 31, 2017.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

1/31/2017

$99M

Acquired

1

Date

1/31/2017

Investment Stage

Companies

Valuation

$99M

Total Funding

Note

Acquired

Sources

1

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.